Dana-Farber Brigham Cancer Center is a clinical research site located in South Weymouth, Massachusetts, United States 02190.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Dana-Farber Brigham Cancer Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: High-risk Smoldering Multiple Myeloma, Multiple Myeloma.
Sponsors: Omar Nadeem, MD.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber Brigham Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber Brigham Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers High-risk Smoldering Multiple Myeloma, Multiple Myeloma.
Dana-Farber Brigham Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.